文献速递肾癌与肾肿瘤男科与性医学

肾细胞癌睾丸转移:系统综述与患者水平Meta分析

Uncovering the Rare: A Systematic Review and Patient-level Meta-analysis of Testicular Metastases From Renal Cell Carcinoma.
PubMed 文献 · Urology · 2025-09-12

中位总生存17个月,无进展生存9个月;淋巴结转移和确诊肾癌时存在转移与死亡相关。同步转移和肺部受累是复发预测因素。

要点

  • 肾癌睾丸转移罕见,中位总生存17个月,无进展生存9个月。
  • 淋巴结转移(OR=15.7)和确诊时转移(OR=6.5)与死亡风险相关。
  • 同步转移(OR=38.5)和肺受累(OR=28.0)是复发预测因素。

核心结论

  • 该Meta分析首次提供肾癌睾丸转移的汇总生存估计和预后模型。
  • 结果支持早期检测的价值,并证实同步疾病和淋巴结播散的预后影响。

研究设计与样本

  • 2025年4月检索PubMed、Scopus、Web of Science和Google Scholar的系统综述与个体患者数据Meta分析。

主要发现

  • 中位总生存17个月(IQR 7.4-26),中位无进展生存9个月(IQR 6-18.5)。
  • Cox回归中,确诊时转移预测较短总生存,肺和淋巴结受累是复发最强预测因素。

临床怎么用

  • 对肾癌患者应警惕睾丸转移可能,早期检测可能改善预后。
  • 同步转移和淋巴结播散患者需加强风险分层和长期监测。

局限性

  • 回顾性个体患者数据,部分变量缺失可能影响分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct the largest and most comprehensive individual patient data (IPD) meta-analysis to date on testicular metastases from renal cell carcinoma (RCC), with the aim of characterizing clinical features, quantifying survival outcomes, and identifying predictors of recurrence and mortality. METHODS: A systematic review was performed in April 2025 using PubMed, Scopus, Web of Science, and Google Scholar. Eligible studies included histologically confirmed testicular metastases from RCC with extractable patient-level data. Fifty-three cases from 40 articles were included. One unpublished case from our institution was included. We extracted demographics, pathology, treatment, imaging, and outcome data. Tumor volume was calculated from ultrasound dimensions using the ellipsoid formula. For bilateral metastases, the mean volume was used in regression analysis. RESULTS: The median overall survival was 17 months (interquartile ranges [IQR], 7.4-26), and progression-free survival was 9 months (IQR, 6-18.5). Lymph node metastasis (odds ratio [OR] = 15.7, P = .019) and presence of metastases at RCC diagnosis (OR = 6.5, P = .034) were associated with mortality. Synchronous metastases (OR = 38.5, P = .002) and lung involvement (OR = 28.0, P = .004) were predictors of recurrence. Survival differed significantly across Fuhrman grades (P = .032) and T stages (P = .047). In Cox regression, metastasis at diagnosis predicted shorter overall survival, while lung and lymph node involvement were the strongest predictors of recurrence. CONCLUSION: This meta-analysis provides the first pooled survival estimates and prognostic modeling for testicular RCC metastases. Findings support the value of early detection and confirm the prognostic impact of synchronous disease and nodal spread. These results establish a foundation for clinical risk stratification and long-term surveillance strategies in affected patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Naushad N, Shendy T, Mahmood T, et al. Uncovering the Rare: A Systematic Review and Patient-level Meta-analysis of Testicular Metastases From Renal Cell Carcinoma. Urology. 2025. PMID: 40946923. doi:10.1016/j.urology.2025.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。